Mesial temporal sclerosis and epilepsy: a narrative review

Daniel Villamizar-Torres1,2, Andrea Carolina Cepeda Trillos3,4, Alejandro Vargas-Moreno1,5

  • 1Member of the neurosurgery research group, Pontificia Universidad Javeriana, Bogotá, 110231, Colombia.

Acta Epileptologica
|April 11, 2025
PubMed

Insights

Mesial temporal sclerosis (MTS) is a common cause of difficult-to-treat epilepsy. This review covers MTS pathology, symptoms, and treatments for better recognition and management.

Area of Science:

  • Neurology
  • Epileptology
  • Pathology

Background:

  • Mesial temporal sclerosis (MTS) is a frequent cause of medically refractory temporal lobe epilepsy.
  • Accurate recognition and suspicion of MTS are vital for effective patient management.
  • Understanding MTS pathophysiology, clinical features, and risk factors is essential.

Purpose of the Study:

  • To provide a comprehensive narrative review of Mesial Temporal Sclerosis (MTS).
  • To consolidate current knowledge on MTS pathophysiology, clinical manifestations, and treatment strategies.
  • To offer an updated perspective on MTS for clinicians and researchers.

Main Methods:

  • Comprehensive literature search for relevant studies on Mesial Temporal Sclerosis (MTS).
  • Narrative review methodology synthesizing existing research findings.
  • Analysis of pathological, clinical, and therapeutic data related to MTS.

Main Results:

  • MTS involves specific pathological alterations in the temporal lobe.
  • Clinical manifestations of MTS include characteristic seizure patterns and neurological deficits.
  • Various treatment options exist, ranging from medication to surgical interventions.

Conclusions:

  • Mesial Temporal Sclerosis (MTS) is a significant cause of intractable epilepsy requiring thorough understanding.
  • Further research into MTS pathophysiology and treatment optimization is warranted.
  • This review provides a valuable resource for the diagnosis and management of MTS.